The sensitivity of clinical isolates of anaerobic species to piperacillin-tazobactam and other antimicrobial agents.
Namavar
F
F
Department of Clinical Microbiology and Infection Control, University Hospital, Vrije Universiteit, Amsterdam, The Netherlands.
Severin
W P
WP
Stobberingh
E
E
Smeets
T
T
MacLaren
D M
DM
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001421:Bacteria, Anaerobic / Q000187:drug effects*; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D010878:Piperacillin / Q000494:pharmacology; D000078142:Tazobactam; D065093:beta-Lactamase Inhibitors
D000900:Anti-Bacterial Agents; D065093:beta-Lactamase Inhibitors; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin